Medical specialists from United Kingdom tagged as investigators in clinical trials studying Thrombocytosis

Total 10 results

Adam Mead
Seen in:
- Oxford, Oxford University Hospitals NHS Foundation Trust, Department of Haematology, Cancer and Haematology Centre, Churchill Hospital
Trials:
- NCT04603495 (Principal Investigator)
Conditions:
Andrew Duncombe, MD
Seen in:
- England, Southampton, University Hospitals Southampton NHS Foundation Trust
Trials:
- NCT01831635 (Principal Investigator)
Conditions:
Andrew Innes
Seen in:
- London, Imperial College Healthcare NHS Trust, Hammersmith Hospital
Trials:
- NCT04603495 (Principal Investigator)
Conditions:
Anna Godfrey
Seen in:
- Cambridge, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Trials:
- NCT04603495 (Principal Investigator)
Conditions:
Ciro Rinaldi, MD
Seen in:
- Boston, Pilgrim Hospital
Trials:
- NCT04603495 (Principal Investigator)
Conditions:
Ioannis Koutsavlis, MD
Seen in:
- Scotland, Edinburgh, Western General Hospital
Trials:
- NCT04603495 (Principal Investigator)
Conditions:
Jonathan Lambert
Seen in:
- London, University College London Hospitals
Trials:
- NCT04603495 (Principal Investigator)
Conditions:
Lesley A Anderson, PhD
Seen in:
- Northern Ireland, Belfast, Queen's University Belfast
Trials:
- NCT01831635 (Principal Investigator)
Conditions:
Mary F Mcmullin, MD
Seen in:
- Northern Ireland, Belfast, Belfast Health and Social Care Trust
Trials:
- NCT01831635 (Principal Investigator)
Conditions:
Steven Knapper, MD
Seen in:
- Wales, Cardiff, University Hospital of Wales
Trials:
- NCT04603495 (Principal Investigator)
- NCT04910685 (Principal Investigator)
Conditions:

Clinical Trials on Thrombocytosis

Assiut University

Not yet recruiting

Aetiology And Outcome Of Children With Thrombocytosis Admitted to Assiut University Children Hospital

Thrombocytosis in Children
Nanfang Hospital, Southern Medical University

Recruiting

The Role of Circ0014614 in the Formation and Development of ET

Primary Thrombocytosis

China
M.D. Anderson Cancer Center
Active Biotech AB

Not yet recruiting

Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-Essential Thrombocytosis Myelofibrosis

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified

United States
Cephalon

Completed

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Polycythemia Vera | Essential Thrombocytosis

United States
National Institutes of Health Clinical Center (CC)

Completed

Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

Polycythemia Vera | Chronic Myeloproliferative Disorders | Essential Thrombocytosis | Idiopathic Myelofibrosis | Neutrophils

United States
Taipei Medical University WanFang Hospital

Completed

Childhood Reactive Thrombocytosis (RT)

Reactive Thromobocytosis in Children

Taiwan
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Molecular Biology of Polycythemia and Thrombocytosis

Polycythemia | Thrombocytosis

United States
Terumo BCT

Completed

Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions (PLTD)

Thrombocytosis | Thrombocythemia | Myeloproliferative Disease

Denmark, Hungary
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Novartis Pharmaceuticals

Completed

LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

United States

Medical specialists from United Kingdom tagged as investigators in clinical trials studying Thrombocytosis

Clinical Trials on Thrombocytosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations